Jasbir Kang

1.1k total citations
8 papers, 794 citations indexed

About

Jasbir Kang is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Jasbir Kang has authored 8 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 2 papers in Pharmacology. Recurrent topics in Jasbir Kang's work include Schizophrenia research and treatment (4 papers), Healthcare Decision-Making and Restraints (2 papers) and Treatment of Major Depression (2 papers). Jasbir Kang is often cited by papers focused on Schizophrenia research and treatment (4 papers), Healthcare Decision-Making and Restraints (2 papers) and Treatment of Major Depression (2 papers). Jasbir Kang collaborates with scholars based in United States and Canada. Jasbir Kang's co-authors include Catherine G. Greeno, M. Katherine Shear, Holly A. Swartz, Ellen Frank, John Battaglia, Sue Moss, A. John Rush, Ricardo Mendoza, Liane J. Leedom and William R. Dubin and has published in prestigious journals such as American Journal of Psychiatry, Movement Disorders and The Journal of Clinical Psychiatry.

In The Last Decade

Jasbir Kang

8 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasbir Kang United States 8 477 418 101 91 62 8 794
Hannah Myles Australia 16 330 0.7× 491 1.2× 166 1.6× 94 1.0× 151 2.4× 27 1.0k
Sanja Kilian South Africa 17 282 0.6× 359 0.9× 36 0.4× 60 0.7× 81 1.3× 51 756
Laurie Harkness United States 12 273 0.6× 135 0.3× 112 1.1× 70 0.8× 83 1.3× 19 783
Enid Rockwell United States 17 166 0.3× 626 1.5× 136 1.3× 65 0.7× 80 1.3× 23 1.0k
Peter Bosanac Australia 15 382 0.8× 247 0.6× 33 0.3× 75 0.8× 61 1.0× 38 639
Ilana B. Glass United Kingdom 12 368 0.8× 473 1.1× 148 1.5× 38 0.4× 121 2.0× 23 829
Geetha Jayaram United States 16 247 0.5× 306 0.7× 83 0.8× 37 0.4× 139 2.2× 52 676
Edna Hamera United States 17 240 0.5× 474 1.1× 39 0.4× 152 1.7× 125 2.0× 50 859
Jentien M. Vermeulen Netherlands 16 240 0.5× 422 1.0× 60 0.6× 53 0.6× 95 1.5× 58 804
Virginia L. Susman United States 9 266 0.6× 525 1.3× 216 2.1× 47 0.5× 44 0.7× 11 794

Countries citing papers authored by Jasbir Kang

Since Specialization
Citations

This map shows the geographic impact of Jasbir Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasbir Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasbir Kang more than expected).

Fields of papers citing papers by Jasbir Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasbir Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasbir Kang. The network helps show where Jasbir Kang may publish in the future.

Co-authorship network of co-authors of Jasbir Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Jasbir Kang. A scholar is included among the top collaborators of Jasbir Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasbir Kang. Jasbir Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chengappa, K. N. Roy, Kenneth A. Perkins, Tracy Anderson, et al.. (2001). Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants. The Journal of Clinical Psychiatry. 62(7). 503–508. 36 indexed citations
2.
Shear, M. Katherine, et al.. (2000). Diagnosis of Nonpsychotic Patients in Community Clinics. American Journal of Psychiatry. 157(4). 581–587. 238 indexed citations
3.
Chengappa, K. N. Roy, et al.. (1999). Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder. The Journal of Clinical Psychiatry. 60(7). 477–484. 104 indexed citations
4.
Battaglia, John, Sue Moss, A. John Rush, et al.. (1997). Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. The American Journal of Emergency Medicine. 15(4). 335–340. 235 indexed citations
5.
Apter, Jeffrey, James A. Halikas, Richard L. Borison, et al.. (1996). The Oral Dose-Effect Relationship for Fluvoxamine: a Fixed-Dose Comparison Against Placebo in Depressed Outpatients. Annals of Clinical Psychiatry. 8(3). 139–151. 41 indexed citations
6.
Hendricks, Shelton E., et al.. (1992). Treatment of fluoxetine-induced anorgasmia with amantadine.. PubMed. 53(6). 212–3. 68 indexed citations
7.
Pfeiffer, Ronald F., Jasbir Kang, Benjamin Graber, Ruth Hofman, & James Wilson. (1990). Clozapine for psychosis in Parkinson's disease. Movement Disorders. 5(3). 239–242. 60 indexed citations
8.
Reid, William H. & Jasbir Kang. (1986). Serious Assaults by Outpatients or Former Patients. American Journal of Psychotherapy. 40(4). 594–600. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026